We serve Chemical Name:2-(3-bromophenyl)-1H-quinolin-4-one CAS:914222-60-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(3-bromophenyl)-1H-quinolin-4-one
CAS.NO:914222-60-9
Synonyms:2-(3-Bromo-phenyl)-1H-quinolin-4-one
Molecular Formula:C15H10BrNO
Molecular Weight:300.15000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:32.86000
Exact Mass:298.99500
LogP:3.95760
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(3-Bromo-phenyl)-1H-quinolin-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3-Bromo-phenyl)-1H-quinolin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-Bromo-phenyl)-1H-quinolin-4-one Use and application,2-(3-Bromo-phenyl)-1H-quinolin-4-one technical grade,usp/ep/jp grade.
Related News: ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. methyl (R)-4-((5S,7R,8R,9S,10S,13R,14S,17R)-7-acetoxy-10,13-dimethyl-3-(2-tosylhydrazineylidene)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate manufacturers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. 4-Chloro-7-hydroxy-2,3-dimethyl-inden-1-one suppliers “From the new company, we’ll be able to provide customers with invaluable access to high-quality sterile fill and finish capacity, which is in huge demand globally,” Recipharm CEO Marc Funk said in a release. Reductase, nitrite (uncultured bacterium clone DGGE band UK4B genenirK fragment) vendor & factory The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction.,Liam McHale, site director for Charles River Ballina said: “We are incredibly proud of the transformational changes we have implemented on site and the role that Charles River has played in supporting the safe and timely rollout of AstraZeneca’s COVID-19 vaccine.
